Novo Nordisk Ukraine
A unique award for the companies of “full age” that reached 18+ years old with the EBA. This is definitely a love for life, because how else to explain such a long relationship? 😊 And we want to go out and tell all the world about it.
The Bravery Award honors companies that fearlessly navigate the turbulent waters of wartime in Ukraine. We are proud of your resilience, remarkable adaptability, and commitment to conducting business in Ukraine.
- Segment: Pharmaceuticals
- Country of origin: Denmark
- In Association since: 2000 year
- Chief: Vlad Moroz Contact the company
The company is world leader in providing diabetes care products as well as other medicines for treatment of growth hormone disorders and hemophilia. Novo Nordisk has 80 years experience in production of insulin and permanently introduces innovative forms of insulin and devices for its administration to diabetic patients in more than 170 countries. The company also develops educational programs for doctors and patients throughout the world which help to improve the quality of diabetes care.